Actively Recruiting
Evaluating Quantitative Ultrasound Bladder Vibrometry for Detecting Detrusor Dysfunction and Guiding BPH Treatment in Adults
Led by Mayo Clinic · Updated on 2026-03-27
2023
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry QUBV to detect abnormal bladder function, specifically focusing on detrusor overactivity and benign prostatic hyperplasia BPH treatment selection. This observational study aims to assess how well QUBV works as a noninvasive tool compared to urodynamic studies, which are part of participants regular clinical care. Participants will undergo QUBV ultrasound at the same time as their scheduled urodynamic study or selective photovaporization of the prostate, depending on their diagnosis and treatment plan. The study will include adults aged 18 to 90 years who are already scheduled for these procedures as part of their clinical care. The research will not involve experimental treatments but will observe and compare QUBV results with standard diagnostic methods. During the study, researchers will measure the accuracy of QUBV in determining detrusor pressure and in selecting BPH patients for surgery. Data will be collected up to study completion, averaging one year. Participants will continue with their usual care, and the study involves no additional interventions beyond the ultrasound measurement performed alongside routine procedures.
CONDITIONS
Brief Title
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
Research Team
A
Azra Alizad, MD
K
Kathryn (Katie) Barthels
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here